Lm Advisors LLC Gilead Sciences, Inc. Transaction History

Lm Advisors LLC

$61.8 Billion
Q2 2024

A detailed history of Lm Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lm Advisors LLC holds 4,197 shares of GILD stock, worth $347,595. This represents 0.89% of its overall portfolio holdings.

Number of Shares

4,197

Holding current value

$347,595

% of portfolio

0.89%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $265,040 - $305,877	4,197 New	4,197 $550 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $256,005 - $290,316	3,494 New	3,494 $283 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$9.99 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.55 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.32 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.91 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $104B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lm Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lm Advisors LLC with notifications on news.

Account